期刊文献+

用布地奈德鼻喷雾剂和盐酸氮卓斯汀喷鼻剂治疗变应性鼻炎的效果对比 被引量:1

Comparison of effect of Budesonide nasal spray and Azelastine hydrochloride nasal spray for treatment of Allergic rhinitis
下载PDF
导出
摘要 目的:对比用布地奈德鼻喷雾剂和盐酸氮卓斯汀喷鼻剂治疗变应性鼻炎的临床效果。方法 :将2015年9月至2016年10月期间在四川省富顺县晨光医院就诊的96例变应性鼻炎患者随机分为传统组与新型组,每组各有48例患者。用布地奈德鼻喷雾剂对传统组患者进行治疗,用盐酸氮卓斯汀喷鼻剂对新型组患者进行治疗。治疗结束后,观察对比两组患者治疗的总有效率、不良反应的发生率和对治疗的满意度。结果 :新型组患者治疗的总有效率明显高于传统组患者,其不良反应的发生率明显低于传统组患者,其对治疗的满意度也高于传统组患者,差异具有统计学意义(P<0.05)。结论 :与用布地奈德鼻喷雾剂治疗变应性鼻炎相比,用盐酸氮卓斯汀喷鼻剂对变应性鼻炎患者进行治疗可显著提高其疗效,降低其不良反应的发生率,进而提高其对治疗的满意度。 Objective To compare effect of budesonide nasal spray and azelastine hydrochloride nasal spray for treatment of allergic rhinitis. Methods Random selected from Chenguang Hospital of Fushun county from September 2015 to October 2016 to receive and treat the patients allergic rhinitis in 96 cases as the research object, and were randomly divided into traditional group and new type group, 48 cases in each group. Treat traditional group with budesonide nasal spray, treat new type group with Azelastine hydrochloride nasal spray. To compare curative rate, adverse effects rate and satisfaction rate. Results The curative rate of new type group is higher than traditional group, adverse effects rate of new type group is lower than traditional group, satisfaction rate of new type group is higher than traditional group, discrepancy of research results of two groups was statistically significant (P 〈 0.05). Conclusion Comparing with budesonide nasal spray treat allergic rhinitis with aselastine hydroehloride nasal spray can improve curative effect and reduce adverse effects rate of patients, then improve satisfaction rate of patients.
作者 陈刚
出处 《当代医药论丛》 2017年第9期16-17,共2页
关键词 变应性鼻炎 布地奈德鼻喷雾剂 盐酸氮卓斯汀喷鼻剂 allergic rhinitis budesonide nasal spray azelastine hydrochloride nasal spray
  • 相关文献

参考文献3

二级参考文献22

  • 1顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1708
  • 2顾之燕.盐酸氮斯汀鼻喷剂治疗变应性鼻炎[J].中华耳鼻咽喉头颈外科杂志,2005,40(9):717-720. 被引量:27
  • 3Brozek JL, Bousquet J, Baena CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision[J].J AI lergy Clin Immunol,2010,126(3):466-476.
  • 4Kenneth K, Gordon S, Jacques H, et al. Desloratadine therapy for symptoms asso- ciated with perennial allergic rhinitis [J]. Ann Allergy Asthma Immuno1,2006,96 : 460 - 465.
  • 5Ricca V, Landi,M, Ferrero P, et al. Minimal persistent inflammation is present at mucosal lecel in patients with asymp tomatic rhinitis and mite allergy[J]. J Allergy Clin Immunol, 2000, 105 (1) : 54-57.
  • 6Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathlolgy in non - atopic asthma, irrespective of the presence of rhnistis[J]. Clin ExpAllergy, 2000, 30 (5) :663-669.
  • 7Bousquet J, Khaltaev N ,Cruz AA, et al. Allergic rhinitis and it simpact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization) [J] . Allergy ,2008,63 (Suppl 86) : 8-160.
  • 8Trangsrud AJ, Whitaker AL, Small RE. Int ranasal corticosteroids for allergic rhi- nitis [J] . Pharmacot herapy, 2002,22(11) :1458-1467.
  • 9Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA ( 2 ) LEN and AllerGen ) [ J ]. Allergy, 2008,63:8 - 160.
  • 10Juniper EF. Measuring health - related quality of life in rhinitis [ J ]. J Allergy Clin lmmunol, 1997,99:742 - 749.

共引文献40

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部